UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Oct

    03

    From Bandages to Bravery: HS Patients Command Times Square in Unforgettable Event

    Read More Share:linkedin| twitter| email| facebook

    Sep

    17

    BIMZELX® (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed Sustained Symptom Relief Across Multiple Clinical Endpoints

    Read More Share:linkedin| twitter| email| facebook

    Sep

    17

    BIMZELX® (bimekizumab-bkzx) Data in Moderate-to-Severe Plaque Psoriasis at EADV Showed Complete Skin Clearance Sustained Over Four Years

    Read More Share:linkedin| twitter| email| facebook

    Sep

    10

    Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care

    Read More Share:linkedin| twitter| email| facebook

    Sep

    10

    Gen Z and Millennial Patients Find “Rheum for Improvement” in Disease Management

    Read More Share:linkedin| twitter| email| facebook

    Sep

    08

    The profound impact on the lives of people living with thymidine kinase 2 deficiency (TK2d)

    Read More Share:linkedin| twitter| email| facebook

    Sep

    03

    The Sniff That Saves: Honoring Service Dogs This Awareness Month

    Read More Share:linkedin| twitter| email| facebook

    Aug

    29

    Decades of Dedication: UCB’s Ongoing Commitment to Epilepsy through the Family Epilepsy Scholarship Program™

    Read More Share:linkedin| twitter| email| facebook

    Aug

    12

    Our Growth Helps Elevate Patient Lives

    Read More Share:linkedin| twitter| email| facebook

    Aug

    05

    UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2025 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: August 2025